Why is InnovAge stock up 14% today?
InnovAge (INNV) stock rose 14.6% in pre-market trading after reporting fiscal Q4 and full-year 2026 results. Adjusted EBITDA increased 175% to $94.6M, revenue grew 15.9% to $989.7M, and net loss narrowed to $0.7M. The company issued fiscal 2027 guidance targeting revenue of $1.05B-$1.085B and adjusted EBITDA of $105M-$115M. CEO Patrick Blair highlighted a strategic focus on scaling through technology, AI, and potential acquisitions.
How this was made
The 30-second read
Why it matters
Earnings beat and forward guidance drove a 14.6% pre‑market surge, suggesting strong short‑term buying pressure.
Market read
The earnings surprise and guidance upgrade provide a clear catalyst for traders, with limited broader market effect.
What to watch
Potential AI integration costs and acquisition spending may temper future profitability.
Background
InnovAge (INNV) is a U.S. senior‑care provider listed on Nasdaq.
Ticker impact
InnovAge reported FY 2026 results with revenue $989.7M (+15.9%), adjusted EBITDA $94.6M (+175%) and near‑breakeven net loss, plus FY 2027 guidance of $1.05‑1.085B revenue and $105‑115M EBITDA, driving a 14.6% pre‑market jump.
Expect continued upside toward the 52‑week high if guidance holds.
The combination of a dramatic EBITDA improvement, revenue beat, and forward guidance creates clear upside momentum.
Market effects
Highlights strength in the senior‑care PACE segment, but peers lack comparable catalysts.
U.S. senior‑care providers may see increased investor interest.
Limited; impact confined to U.S. healthcare equities.
Counterpoint
The near‑breakeven net loss and modest EPS miss could signal underlying margin pressure.
Key entities
- CompanyInnovAge
Senior‑care provider reporting FY 2026 results.
- ExecutivePatrick Blair
CEO of InnovAge who commented on the results.
